T900607 / Amgen 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
T900607 / Amgen
ACTRN12623000300673: First in human clinical study of a novel drug PTC607 to assess effects of food intake and to compare PTC607 levels, when taken as an oral suspension and tablet formulation.

Completed
1
8
 
CTI Clinical Trial and Consulting Services Australia Pty Ltd., PTC Therapeutics, Inc.
Huntington's Disease
 
 
ACTRN12622001534774: First in human clinical study of a novel drug PTC607 to assess its safety and tolerability in healthy volunteers

Completed
1
40
 
CTI Clinical Trial and Consulting Services Australia Pty Ltd., PTC Therapeutics, Inc.
Huntington's Disease
 
 

Download Options